Search details
1.
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Ann Neurol
; 95(3): 459-470, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37974536
2.
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
J Neuroinflammation
; 21(1): 52, 2024 Feb 17.
Article
in English
| MEDLINE | ID: mdl-38368354
3.
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort.
Neuroepidemiology
; 58(3): 218-226, 2024.
Article
in English
| MEDLINE | ID: mdl-38377969
4.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Eur J Neurol
; 31(7): e16289, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38567516
5.
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Ann Neurol
; 91(1): 89-100, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34687063
6.
Decentralised clinical trials in multiple sclerosis research.
Mult Scler
; 29(3): 317-325, 2023 03.
Article
in English
| MEDLINE | ID: mdl-35735014
7.
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Mult Scler
; 29(8): 979-989, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37431627
8.
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register.
Mult Scler
; 28(7): 1060-1071, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34080892
9.
Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline.
Pract Neurol
; 2022 Jul 21.
Article
in English
| MEDLINE | ID: mdl-35863879
10.
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study.
Mult Scler
; 27(7): 1088-1101, 2021 06.
Article
in English
| MEDLINE | ID: mdl-32749927
11.
MRI: how to understand it.
Pract Neurol
; 21(3): 216-224, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33963086
12.
Tractography in the presence of multiple sclerosis lesions.
Neuroimage
; 209: 116471, 2020 04 01.
Article
in English
| MEDLINE | ID: mdl-31877372
13.
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis.
Hum Brain Mapp
; 40(10): 2917-2932, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30891838
14.
Using biomarkers to predict clinical outcomes in multiple sclerosis.
Pract Neurol
; 19(4): 342-349, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31243138
15.
Rituximab in neurological disease: principles, evidence and practice.
Pract Neurol
; 19(1): 5-20, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30498056
16.
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: No.
Mult Scler
; 28(8): 1175-1177, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35485436
17.
The aetiology of acute neurological decline in multiple sclerosis: experience from an open-access clinic.
Mult Scler
; 21(1): 67-75, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-24948684
18.
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis.
Mult Scler
; 24(13): 1786-1787, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29762077
19.
Incidence of persistent lymphopenia in people with multiple sclerosis on dimethyl fumarate.
Mult Scler Relat Disord
; 58: 103492, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35066268
20.
Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial.
Pilot Feasibility Stud
; 8(1): 123, 2022 Jun 11.
Article
in English
| MEDLINE | ID: mdl-35690797